• Pre-existing and early cellular immune factors correlate with functionally complete protection against primary controlled human SARS-CoV-2 infection 07.12.2025

• Temporal Profiling of SARS-CoV-2 Variants Using BioEnrichPy:
  A Network-Based Insight into Host Disruption and Neurodegeneration 07.12.2025

• Single-Chain Variable Fragment Based Dot Blot, Single and Multiple Assays for Rapid SARS-CoV-2 Diagnostics 07.12.2025

• Esophageal motility disorders after COVID-19 infection. 06.12.2025

• Impact of pre-existing anti-replicase immunity on the efficacy of self-amplifying mRNA vaccines. 06.12.2025

• MAAD:
  Multidimensional Antiviral Antibody Database. 06.12.2025

• Single-Chain Variable Fragment Based Dot Blot, Single and Multiple Assays for Rapid SARS-CoV-2 Diagnostics. 06.12.2025

• COVID-19-associated large-vessel vasculitis with elevated anti-angiotensin converting enzyme 2 antibody:
  three cases and a review of the literature. 06.12.2025

• Vaccination and vitamin D in relation to disease severity and mortality in patients with COVID-19 disease:
  a follow-up study. 06.12.2025

• Comparison of T Cell Immune Responses Against SARS-CoV-2 Using QuantiFERON SARS-CoV-2 Assay Versus Peripheral Blood Mononuclear Cells Analysis by Flow Cytometry 06.12.2025

• A single extracellular vesicle-based platform supporting both RBD protein and mRNA vaccination against SARS-CoV-2 06.12.2025

• Antibody escape of SARS-CoV-2 variants of concern on receptor-binding domain:
  A computational approach 06.12.2025

• Persistent Symptoms in SARS‐CoV‐2‐Infected and Non‐Infected Household Members:
  A Prospective Cohort Study 06.12.2025

• Virtual lab of artificial intelligence agents accelerating nanobody design against SARS-CoV-2 variants 06.12.2025

• Impact of SARS-CoV-2 omicron variant on placental pathology and perinatal outcomes:
  a retrospective comparison of vaccinated, partially vaccinated and unvaccinated pregnant women 06.12.2025

• Does peptidome mimicry shape host-parasite coevolution? 05.12.2025

• The Application of a Protocol for Virtual Certifying Examinations:
  Five-Year Results (2020-2024). 05.12.2025

• Single-molecule nanopore profiling of protein domain fragment dynamics and aggregation. 05.12.2025

• Trend and quality of care for diabetic patients in diabetes outpatient clinics before and during the COVID-19 pandemic. 05.12.2025

• Examining the severity of illness in pregnant women infected with COVID-19 during three waves of the disease in Ahvaz, Iran. 05.12.2025

• WSK-V102C COVID-19 vaccine effectiveness against SARS-CoV-2 JN.1 symptomatic infection among adults 60 years and older:
  a prospective observational cohort study in Shaanxi Province, China, 2024. 05.12.2025

• Identification of mathematical patterns in genomic spectrograms linked to variant classification in complete SARS-CoV-2 sequences. 05.12.2025

• Immunologic and biophysical features of the BNT162b2 JN.1 and KP.2 adapted COVID-19 vaccines. 05.12.2025

• Heterologous expression of HCoV-HKU1 ORF 7b by mouse hepatitis virus protects against severe disease during murine infection. 05.12.2025

• Depression and anxiety mediate the relationship between COVID-19 stay-at-home orders and tobacco and marijuana use. 05.12.2025

• A synthetic control evaluation of the use of pulse oximeters in response to the COVID-19 pandemic in England. 05.12.2025

• Diné traditional medicine use and wellbeing among navajo adults during the COVID-19 pandemic:
  A cross-sectional study. 05.12.2025

• A rapid evaluation of the UK Health Security Agency's New Variant Assessment Platform global genomic surveillance programme. 05.12.2025

• Radon exposure and COVID-19 mortality in pre-vaccination period:
  What links might exist? 05.12.2025

• Impact of Risk Stacking on COVID-19-Related Healthcare Utilization:
  A Real-World Retrospective Cohort Study. 05.12.2025

• Clinical Features and Short-term Outcomes of 144 Patients With SARS in the Greater Toronto Area—Correction 05.12.2025

• WHO:
  Boost SARS Surveillance 05.12.2025

• Is SARS Just ARDS? 05.12.2025

• Companies Warned About Unproven SARS Treatments 05.12.2025

• Post-quadri-vaccinal SARS-CoV-2 antibodies in Vietnamese patients with end-stage renal disease:
  A prospective cohort study 05.12.2025

• Disentangling Origin of the SARS-CoV-2 FCS from Emerging Risk:
  Convergent Biorisk Hazards via DNA-Repair Mechanisms, RNA Oncogenic Viruses, and Possible Covert Laboratory Experiments 05.12.2025

• Emergence of intra-host diversity and transmission of genomic mutation observed in a small clinical setting:
  During a household COVID-19 infection in a three-member family, three mutations emerged in the SARS-CoV-2 genome, with one being transmitted 05.12.2025

• SARS-CoV-2 inactivation and scRNAseq sample preparation protocol v1 05.12.2025

• Enhanced Subchronic Cardiac Stress of High Doses of a Novel SARS-CoV-2 mRNA Vaccine Candidate in Streptozotocin-Induced Diabetic Mice 05.12.2025

• Evaluation of ∑-MM™ Molecular Medium for the SARS-CoV-2 RNA stability over 90 days under different temperature conditions. 05.12.2025

• Nanotechnological approaches for COVID-19 management:
  Highlighting the impact on SARS-Co-V-2 variants 05.12.2025

• Engineered nanoparticles for the management of COVID-19 and new variants of SARS-CoV-2 05.12.2025

• Coronavirus disease 2019 and the SARS-CoV-2 variants:
  Virological perspectives 05.12.2025

• Nanotechnology-assisted therapeutic antibodies against SARS-CoV-2 variants:
  Current findings and future perspectives 05.12.2025

• Nature’s arsenal:
  Combatting SARS-CoV-2 variants with phytocompound nanoparticles 05.12.2025

• Nanotechnology-based drug delivery for combating SARS-CoV-2 variants 05.12.2025

• Anti-SARS-CoV-2 nanoparticles:
  Mechanisms and applications 05.12.2025

• Nanomaterial-based therapeutic drugs for SARS-CoV-2 variants:
  Recent findings, limitations, and prospects 05.12.2025

• Nanotechnology for the prevention of SARS-CoV-2 infection 05.12.2025

• COV-FCE-Based Evaluation of Old Community Fire Resilience:
  A Case Study of Xuzhou City, China 05.12.2025

• Cognitive performance and narrative discourse after SARS-CoV-2 infection 05.12.2025

• Resistance of endothelial cells to SARS-CoV-2 infection in vitro 05.12.2025

• Impact of prolonged infection on SARS-CoV-2 evolution 05.12.2025

• Μελέτη επίδρασης ενός προγράμματος καρδιοπνευμονικής αποκατάστασης, στην ενδοθηλιακή λειτουργία, αρτηριακή σκληρία και καρδιακή λειτουργία ασθενών μετά από λοίμωξη SARS-CoV2 05.12.2025

• Paediatric autoimmune thyroiditis triggered by prior SARS-CoV-2 exposure:
  a case with transient hashitoxicosis 05.12.2025

• Dynamical Fragment Molecular Orbital Interaction Analysis of SARS-CoV2 RNA-Dependent RNA Polymerase and Remdesivir 05.12.2025

• Design of a 2D Melting Curve–Based Multiplex PCR Assay for Detection of SARS‐CoV‐2/RSV/Influenza A‐B 05.12.2025

• Dynamical Fragment Molecular Orbital Interaction Analysis of SARS-CoV-2 RNA-Dependent RNA Polymerase and Remdesivir 05.12.2025

• SARS-Cov-2 Vaccination in Patients with Inborn Errors of Immunity in Latvia:
  Immune Response and Reasons for Refusal of Recommended Vaccination. Summary of the Doctoral Thesis 05.12.2025

• SARS-CoV-2 vakcinācija iedzimto imunitātes traucējumu pacientiem Latvijā:
  imūnās atbildes reakcija un iemesli atteikumam no rekomendētas vakcinācijas. Promocijas darba kopsavilkums 05.12.2025

• SARS-CoV-2 vakcinācija iedzimto imunitātes traucējumu pacientiem Latvijā:
  imūnās atbildes reakcija un iemesli atteikumam no rekomendētas vakcinācijas. Promocijas darbs 05.12.2025

• RISK OF EXPOSURE TO BIOAEROSOLS IN CLINICAL ENVIRONMENTS:
  BRONCHOSCOPY. 04.12.2025

• The lingering shadow of epidemics:
  post-acute sequelae across history. 04.12.2025

• The association between COVID-19 vaccination with the prevalence of post-COVID conditions in Thai patients with mild COVID-19. 04.12.2025

• Integrated systems vaccinology reveals distinct metabolic responses to SARS-CoV-2 infection and DNA-based vaccines in ferrets. 04.12.2025

• Lung infection in orally inoculated SARS-CoV-2 hamsters. 04.12.2025

• Are Antibodies Sufficient For Protection Against SARS-CoV-2 Infections? 04.12.2025

• Pathogen-specific immunity debt in children after prolonged nonpharmaceutical interventions:
  a cross-sectional study in China. 03.12.2025

• The role of therapeutic cancer vaccines in the modern immunotherapy era:
  State of the art with recent progress and future challenges. 03.12.2025

• Plasmatic biochemical changes in COVID-19:
  relevant markers that reflect patient genotypic predisposal. 03.12.2025

• VACCINATION UTILIZATION IN PATIENTS WITH PULMONARY HYPERTENSION. 03.12.2025

• Post COVID-19 pandemic Inflammatory Insights into Cancer:
  Consequences for immunotherapy. 03.12.2025

• The Role of ACE2 in SARS-CoV-2 Infection, Pathogenesis, and Antiviral Interventions. 01.12.2025

• Placental infection by SARS-CoV-2:
  exploring alternative entry pathways. 30.11.2025

• Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection. 28.11.2025

• Tragedy or ordeal? How reshaping discourses can contribute to reimagining approaches to care and the value of life in times of crisis. 27.11.2025

• Spumigins produced by Nodularia spumigena are natural serine protease inhibitors with anti-SARS-CoV-2 activity. 27.11.2025

• Tracking SARS-CoV-2 transmission:
  evaluation of the Québec wastewater surveillance program. 27.11.2025

• Effect of the S2' site cleavage on SARS-CoV-2 spike. 27.11.2025

• Enhancing One Health Through Wastewater-Based Surveillance:
  Development and Validation of a Multiplex ddPCR Tool to Differentiate Human and Livestock Contributions. 23.11.2025

• SARS-CoV-2 vaccination and myositis in Norway and Sweden. 22.11.2025

• Presence of SARS-CoV-2 in fetal organs via intraamniotic infection. 21.11.2025

• C > U mutations generate immunogenic peptides in SARS-CoV-2. 19.11.2025

• The Mac1 ADP-ribosylhydrolase is a therapeutic target for SARS-CoV-2. 19.11.2025

• Evolutionary rewiring of host metabolism and interferon signalling by SARS-CoV-2 variants 17.11.2025

• P selectin promotes SARS-CoV-2 interactions with platelets and the endothelium. 17.11.2025

• Pharmacological reprogramming of plitidepsin as a SARS-CoV-2 inhibitor. 10.11.2025

• SARS-CoV-2 variants:
  biology, pathogenicity, immunity and control. 10.11.2025

• Comparing Morbidity of Infants Hospitalised With RSV or SARS-COV-2. 08.11.2025

• Novel method for the identification of circulating SARS-CoV-2 variants and clinical characteristics of patient infection with SARS-CoV-2 variants in Central China. 04.11.2025

• SARS-CoV-2:
  A Liver Brief. 01.11.2025

• Co-Infection With Hepatitis E Virus and SARS-CoV-2 in a Lymphoma Patient. 01.11.2025

• Evolution and Viral Properties of the SARS-CoV-2 BA.3.2 Subvariant 29.10.2025

• SARS-CoV-2 infection and exposure in cats and dogs in Romania. 29.10.2025

• Neurological Manifestations of SARS-CoV-2. 28.10.2025

• Impact of SARS-CoV-2 infection on perioperative mortality. 25.10.2025

• Acute SARS-CoV-2 infection. 24.10.2025

• Acute SARS-CoV-2 infection. 24.10.2025

• The seven enigmas of SARS-CoV-2:
  from the past to the future 24.10.2025

• The Effect of SARS-COV-2 Protein Fragments on the Dimerization of α-Synuclein. 22.10.2025

Quellen: PubMed, Europe PMC & CrossRef